{"version":"1.0","type":"link","title":"Neoadjuvant FOLF(IRIN)OX Chemotherapy for Resectable Pancreatic Adenocarcinoma: A Multicenter Randomized Noncomparative Phase II Trial (PANACHE01 FRENCH08 PRODIGE48 study).","author_name":"Schwarz L 외","author_url":"https://prs-insight.online/author/Schwarz%20L","provider_name":"PRSinsight","provider_url":"https://prs-insight.online","thumbnail_url":"https://prs-insight.online/og/paper/152913","thumbnail_width":1200,"thumbnail_height":630}